For the KD-CAAP study the first site is open for patient recruitment into KD-CAAP Study.
Dr. Paul Brogan, KD-CAAP study sponsor, spoke about the value of the c4c consortium: “c4c has provided a paediatric network to deliver clinical trials for children in the UK and Europe. This vision will be transformative for more efficient and rapid delivery of clinical trials in paediatrics, [which is] much-needed. In the future it will also facilitate better working with pharma, thus allowing study of novel therapeutics for children”
Within c4c national hubs were developed. Pedmed-NL is the Dutch national hub, the single point of contact for The Netherlands.
Read full presse release here: https://lnkd.in/drdfDUW.